HOME >> MEDICINE >> NEWS
Autism conference reports advances in early diagnosis, role of immune system and more

BOSTON, Mass. (May 5, 2005) - Some 700 scientists from around the world who gathered in Boston this week shared exciting advances in understanding the causes of and treatments for autism disorders, which affect up to one of every 166 people. Autism is a brain disorder that can severely impair a child's communication and social skills, leaving them in apparent isolation from their families and communities.

"A critical mass of scientists and the new tools of molecular biology are deepening our understanding of autism at a breathtaking pace," said Helen Tager-Flusberg, chair of the conference and a professor at the Boston University School of Medicine. "The immune system, behavior, genetics, and the environment all factor in to this complex and devastating disease. We are putting the pieces together."

Among the advances reported by scientists were:

  • Early Detection: Identification of both potential biological markers in the blood (biomarkers) and behaviors that will allow scientists and physicians to identify autism in infants, and thus initiate early treatment.
  • Immune System: Strong evidence that autism may be a disorder involving the immune system as well as a disorder of the brain.
  • Genetics: Studies homed in on chromosomal regions implicated in autism. Exciting results came from looking at autistic-like traits.
  • Environment: Scientists documented overlap between environmentally responsive genes and genes associated with autism, and found evidence into the potential role of environmental toxins such as PCBs.

Scientists reported their findings at the 4th International Meeting for Autism Research (IMFAR). The UC Davis M.I.N.D. Institute, Cure Autism Now, and the National Alliance for Autism Research initiated the annual conference, which is the most extensive exploration of research advances in autism.

Early Detection


'"/>


5-May-2005


Page: 1 2 3 4 5

Related medicine news :

1. National Autism Conference slated for June
2. $7.5 million NIH grant to Yale for Autism Center of Excellence
3. The eyes have it -- Autism research yields surprising results
4. Autism has high costs to US society
5. Autism Speaks makes major funding commitment for unprecedented national autism database
6. Autism problems explained in new research
7. Autism and X-fragile syndrome
8. Cedars-Sinai researchers present new endocrine findings at 2 international conferences
9. WFU to host international conference of physicists
10. Sight specialists to shed light on vision loss at UH conference
11. University of Alberta hosts international conference on women in the knowledge economy and society

Post Your Comments:
(Date:5/23/2013)... May 23, 2013 Better Life Maids of ... it prepares to launch its one of a kind green ... management staff will be completed May 29th, and a soft ... Richardson completed on site training in Portland recently and will ... complete operational training. , "It really is a lot to ...
(Date:5/23/2013)... PhD Box has introduced a ... the research process by offering assistance for Thesis Proposals. The ... of services that the company provides for research consultation in ... dedicated proposal writing service is that this is the stage ... research process find it difficult to draft a proposal as ...
(Date:5/23/2013)... 2013 Footwear etc. is pleased to announce ... of sandals containing cork footbeds. Known for its extremely supportive ... sales for many years, and with this new collection is ... , Dansko Shoes and Sandals are renowned for ... no exception. Containing leather and patent leather uppers in metallic ...
(Date:5/23/2013)... Following the recent outbreak of fake ... the security team at idcloak Technologies has identified a ... or any web-born malware. Gill-Chris Welles of the ... better privacy and security than traditional antivirus ... the best AV software cannot be depended on: it ...
(Date:5/23/2013)... 23, 2013 Long-Term Care Insurance ... the rate at which applicants for Long Term Care Insurance ... , The decision to buy a Long Term ... consumers willing and able to purchase protection are increasingly being ... at any price. A variety of chronic conditions appear ...
Breaking Medicine News(10 mins):Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3
(Date:5/22/2013)... , May 22, 2013 Pomerantz ... investigating claims on behalf of investors of Intuitive Surgical, ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical common ... (the "Class Period"). Such investors are advised to contact ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
Cached News: